Sylvie Peltier

Dr Sylvie Peltier is the Head of Global Regulatory Affairs, responsible for defining and implementing the regulatory strategy for ModeX Therapeutics assets. She brings more than three decades of Regulatory experience where she oversaw the full life cycle of small, large molecules and cell therapies. Sylvie was most recently SVP Global Regulatory Affairs at Carsgen Therapeutics, where she oversaw the first CAR-T approval for the company in China and the globalization of the regulatory activities with the development of CAR-T in solid tumors and hemato-oncology. Before Sylvie led the Regulatory Affairs US at Morphosys with the approval of Monjuvi (tafasitamab). Sylvie worked also in mid-size companies and major ones such as Pfizer in various national, regional or global regulatory positions.

Sylvie earned her PharmD and Master in Health Laws from University of Paris XI.